(Q38286190)

1 September 2017

1 reference

title

Immunoadsorption therapy in dilated cardiomyopathy (English)

1 reference

1 September 2017

Marcus Dörr

3

0 references

author name string

Stephan B Felix

series ordinal

1

1 reference

PubMed ID

25494978

1 September 2017

Daniel Beug

series ordinal

2

1 reference

1 September 2017

13 December 2014

1 reference

Expert Review of Cardiovascular Therapy

1 September 2017

1 reference

1 September 2017

13

1 reference

1 September 2017

2

1 reference

1 September 2017

145-152

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

1 September 2017

1 reference

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Myocarditis: current trends in diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Immunohistochemistry in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Antibody-mediated enhancement of calcium permeability in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

A synthetic peptide corresponding to the second extracellular loop of the human M2 acetylcholine receptor induces pharmacological and morphological changes in cardiomyocytes by active immunization after 6 months in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Autoantibodies in heart failure and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Modulation of the cellular immune system by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Immunoadsorption as treatment option in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Ig apheresis for the treatment of severe DCM patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.2015.990385

10.1586/14779072.2015.990385

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25494978